Therapeutic application of regeneration-associated cells: a novel

Chronic diseases with comorbidities or associated risk factors may impair the function of regenerative cells and the regenerative microenvironment. Following this consideration, the vasculogenic conditioning culture (VCC) method was developed to boost the regenerative microenvironment to achieve regeneration-associated cells (RACs), which contain vasculogenic endothelial progenitor cells (EPCs) and anti-inflammatory/anti-immunity cells. Preclinical and clinical studies demonstrate that RAC transplantation is a safe and convenient cell population for promoting ischemic tissue recovery based on its strong vasculogenicity and functionality. The outputs of the scientific reports reviewed in the present study shed light on the fact that RAC transplantation is efficient in curing various diseases. Here, we compactly highlight the universal features of RACs and the latest progress in their translation toward clinics.

Mehdi Hassanpour on LinkedIn: I'm so pleased to share that I'm

Endothelial PGC-1α mediates vascular dysfunction in diabetes

SDF1 gradient associates with the distribution of c-Kit+ cardiac cells

Endothelial Progenitor Cells inhibit jaw osteonecrosis in a rat

Effect of Repetitive Intra-Arterial Infusion of Bone Marrow

Regeneration-associated cells increased post-QQ culturing. (A) The

Interleukin-10 Deficiency Impairs Reparative Properties of Bone

Interleukin-10 Deficiency Impairs Reparative Properties of Bone

Effect of Repetitive Intra-Arterial Infusion of Bone Marrow

Chronological development of EPC-based cell therapies. Since EPCs

Effect of Repetitive Intra-Arterial Infusion of Bone Marrow